Insider Trading & Ownership - RVL PHARMACEUTICALS PLC (RVLPQ)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for RVL PHARMACEUTICALS PLC
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-19
Sale
2023-10-23
4:23 pm
RVL Pharmaceuticals plcRVLPHarsaul Foundation
10% Owner
14,122,659$0.04108$580,1474,941,101
(Indirect)
View
2023-10-19
Sale
2023-10-23
1:06 pm
RVL Pharmaceuticals plcRVLPAltchem Ltd
Orbit Co-Invest A-1 LLC
10% Owner
14,122,659$0.04108$580,1476,123,344
(Indirect
Direct)
View
2023-10-18
Sale
2023-10-20
3:59 pm
RVL Pharmaceuticals plcRVLPHarsaul Foundation
10% Owner
3,421,537$0.0646$221,03119,063,760
(Indirect)
View
2023-10-18
Sale
2023-10-20
1:36 pm
RVL Pharmaceuticals plcRVLPAltchem Ltd
Orbit Co-Invest A-1 LLC
10% Owner
3,421,537$0.0646$221,03120,246,003
(Indirect
Direct)
View
2022-08-08
Purchase
2022-08-09
5:23 pm
RVL Pharmaceuticals plcRVLPSchaub James
EVP and COO
150,000$1.55$232,500540,020
(Direct)
View
2022-08-08
Purchase
2022-08-09
5:22 pm
RVL Pharmaceuticals plcRVLPMARKISON BRIAN A
Chief Executive Officer
850,000$1.55$1,317,5002,976,020
(Direct)
View
2022-08-08
Purchase
2022-08-09
5:21 pm
RVL Pharmaceuticals plcRVLPBurgstahler David F
Director
10% Owner
8,000,000$1.55$12,400,00024,763,859
(Indirect)
View
2022-08-08
Purchase
2022-08-09
5:19 pm
RVL Pharmaceuticals plcRVLPVenkataraman Sriram
Director
10% Owner
8,000,000$1.55$12,400,00024,763,859
(Indirect)
View
2022-08-08
Purchase
2022-08-09
5:18 pm
RVL Pharmaceuticals plcRVLPAvista Healthcare Partners L.P.
Avista Healthcare Partners GP Ltd.
Avista Capital Partners III GP L.P.
Orbit Co-Invest III LLC
10% Owner
8,000,000$1.55$12,400,00024,763,859
(Indirect
Direct)
View
2021-12-16
Purchase
2021-12-20
5:03 pm
Osmotica Pharmaceuticals plcOSMTSchaub James
EVP and COO
93,800$1.07$100,366405,900
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-08-15
Other
2023-08-17
5:04 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPAvista Healthcare Partners GP Ltd.
Avista Healthcare Partners L.P.
10% Owner
23,730,864$023,730,864
(Indirect)
View
2023-08-10
Tax Withholding
2023-08-14
5:35 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPLask Alisa
Director
12,000$0.49112,557
(Direct)
View
2023-07-05
Option Award
2023-07-11
9:17 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPDeBiasi Michael J.
Director
40,000$040,000
(Direct)
View
2023-07-05
Option Award
2023-07-11
9:16 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPCOWAN GREGORY L
Director
40,000$090,055
(Direct)
View
2023-07-05
Option Award
2023-07-11
9:15 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPLask Alisa
Director
40,000$0124,557
(Direct)
View
2023-05-18
Tax Withholding
2023-05-22
9:21 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPSchaub James
EVP and COO
5,577$0.87524,835
(Direct)
View
2023-05-18
Tax Withholding
2023-05-22
9:18 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPKlein Christopher
General Counsel & Secretary
5,447$0.87180,573
(Direct)
View
2023-01-27
Other
2023-01-30
5:29 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPBurgstahler David F
Director
10% Owner
1,032,995$024,763,859
(Indirect)
View
2023-01-27
Other
2023-01-30
5:28 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPVenkataraman Sriram
Director
10% Owner
1,032,995$024,763,859
(Indirect)
View
2023-01-27
Other
2023-01-30
5:27 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPAvista Capital Partners III GP L.P.
Orbit Co-Invest III LLC
Avista Healthcare Partners GP Ltd.
Avista Healthcare Partners L.P.
10% Owner
1,032,995$024,763,859
(Indirect)
View
2023-01-24
Tax Withholding
2023-01-26
5:16 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPKlein Christopher
General Counsel & Secretary
9,608$1.26186,020
(Direct)
View
2023-01-24
Tax Withholding
2023-01-26
5:15 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPSchaub James
EVP and COO
9,608$1.26530,412
(Direct)
View
2022-08-10
Option Award
2022-08-12
4:07 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPLask Alisa
Director
75,000$084,557
(Direct)
View

Ownership
2022-08-12
4:05 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPLask Alisa
Director
0$09,557
(Direct)
View

Ownership
2022-08-12
11:37 am
N/A
N/A
RVL Pharmaceuticals plcRVLPAthyrium Opportunities IV Acquisition 2 LP
Athyrium Opportunities IV Co-invest 2 LP
Athyrium Opportunities Associates IV LP
Athyrium Opportunities Associates IV GP LLC
Athyrium Funds GP Holdings LLC
Athyrium Opportunities Associates IV Co-Invest LLC
Ferrell Jeffrey
10% Owner
0$016,600,444
(Indirect)
View
2022-05-18
Tax Withholding
2022-05-20
4:28 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPdeVries Tina Marie
EVP, Research & Development
5,447$1.4136,141
(Direct)
View
2022-05-18
Tax Withholding
2022-05-20
4:27 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPKlein Christopher
General Counsel & Secretary
6,127$1.4195,628
(Direct)
View
2022-05-18
Tax Withholding
2022-05-20
4:25 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPSchaub James
EVP and COO
6,273$1.4390,020
(Direct)
View
2022-01-24
Tax Withholding
2022-01-26
4:31 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPEinhorn Andrew J.
Chief Financial Officer
9,607$1.13164,325
(Direct)
View
2022-01-24
Tax Withholding
2022-01-26
4:31 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPKlein Christopher
General Counsel & Secretary
9,607$1.13201,755
(Direct)
View
2022-01-24
Tax Withholding
2022-01-26
4:31 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPdeVries Tina Marie
EVP, Research & Development
9,607$1.13141,588
(Direct)
View
2022-01-24
Tax Withholding
2022-01-26
4:30 pm
N/A
N/A
RVL Pharmaceuticals plcRVLPSchaub James
EVP and COO
9,607$1.13396,293
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:09 pm
N/A
2031-11-04
Osmotica Pharmaceuticals plcOSMTdeVries Tina Marie
EVP, Research & Development
216,944$0216,944
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:07 pm
N/A
2031-11-04
Osmotica Pharmaceuticals plcOSMTSchaub James
EVP and COO
249,814$0249,814
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:06 pm
N/A
2031-11-04
Osmotica Pharmaceuticals plcOSMTKlein Christopher
General Counsel & Secretary
249,814$0249,814
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:06 pm
N/A
2031-11-04
Osmotica Pharmaceuticals plcOSMTEinhorn Andrew J.
Chief Financial Officer
249,814$0249,814
(Direct)
View
2021-11-04
Option Award
2021-11-08
4:05 pm
N/A
2031-11-04
Osmotica Pharmaceuticals plcOSMTMARKISON BRIAN A
Chief Executive Officer
615,000$0615,000
(Direct)
View
2021-08-27
Tax Withholding
2021-09-03
4:02 pm
N/A
N/A
Osmotica Pharmaceuticals plcOSMTCOWAN GREGORY L
Director
5,506$3.3150,055
(Direct)
View
2021-08-27
Tax Withholding
2021-09-03
4:01 pm
N/A
N/A
Osmotica Pharmaceuticals plcOSMTWEISS FRED G
Director
5,506$3.31118,466
(Direct)
View
Goto 0, 1, Next